News for hackers. Stuff that matters.
Re:Open-weight AI is having its Kubernetes moment. Let's not... by ncallaway on Saturday July 25, 2026 @01:27PM (#49049611)
The government backed monopoly to ensure that supply remains artificially restricted to ensure that the market will support the higher prices is
Re:Open-weight AI is having its Kubernetes moment. Let's not... by andsoitis on Saturday July 25, 2026 @01:45PM (#49049811)
Drug companies have a portfolio of compounds they research. Most don’t pay off, so R&D costs make their way into the pricing of those superstar and other drugs that do work. Also, timelines are pretty long.
Re:Open-weight AI is having its Kubernetes moment. Let's not... by mjhay on Saturday July 25, 2026 @01:59PM (#49049953)
Drug companies spend more on marketing than R&D
Re:Open-weight AI is having its Kubernetes moment. Let's not... by andsoitis on Saturday July 25, 2026 @02:47PM (#49050405)
So?
Re:Open-weight AI is having its Kubernetes moment. Let's not... by DennisP on Saturday July 25, 2026 @03:32PM (#49050742)
So pharmaceutical companies spend far less on marketing outside the US, partly because every other country besides New Zealand makes those incessant drug ads illegal, and partly because government negotiate prices and keep profit margins down. If the argument is that R&D costs are what make drugs expensive, then we could easily eliminate an even greater expense by just copying what other developed nations do.
Re:Open-weight AI is having its Kubernetes moment. Let's not... by andsoitis on Saturday July 25, 2026 @05:29PM (#49051792)
Don’t you think drug companies would be doing that (not advertise) if it would increase their profit?
Re:Open-weight AI is having its Kubernetes moment. Let's not... by DennisP on Saturday July 25, 2026 @05:56PM (#49052010)
Of course advertising increases their profit. It does that by increasing their revenue even more than the cost of the advertising.

For the rest of us, that giant increase in revenue is an increase in our healthcare costs.

Re:Open-weight AI is having its Kubernetes moment. Let's not... by andsoitis on Saturday July 25, 2026 @07:52PM (#49053064)
Ah so sounds like your logic is: ban advertising -> less costs -> less revenue & lower patient costs -> same profit.

I think I can spot a flaw in that logic.

Re:Open-weight AI is having its Kubernetes moment. Let's not... by DennisP on Saturday July 25, 2026 @08:28PM (#49053327)
That last step contradicts my previous comment.
Re:Open-weight AI is having its Kubernetes moment. Let's not... by ncallaway on Saturday July 25, 2026 @06:13PM (#49052192)
Well, R&D costs are able to make their way into the pricing due to the artificial supply restriction.

If supply was not artificially restricted (through patents), then competitors would be able to manufacture the drug, supply would expand, the price would collapse, and the original inventor would not be able to recover their R&D costs.

Re:Open-weight AI is having its Kubernetes moment. Let's not... by derektank on Saturday July 25, 2026 @01:49PM (#49049846)
In that light, the entire market itself looks essentially artificial, given drug manufacturing couldn’t exist without government guaranteed property rights, which are themselves a kind of monopoly on use.

But yes, the reason brand name drugs are drugs are more expensive than generics is due to intellectual property, both the patent and the trademark.

Re:Open-weight AI is having its Kubernetes moment. Let's not... by octopoc on Saturday July 25, 2026 @02:46PM (#49050397)
Without temporary monopolies granted by patents, those prescription medications wouldn’t exist in the first place.
Re:Open-weight AI is having its Kubernetes moment. Let's not... by DennisP on Saturday July 25, 2026 @04:23PM (#49051172)
Unless we came up with a different funding mechanism. Joseph Stiglitz for example has advocated a prize system for pharmaceuticals, though he doesn't suggest replacing the patent system entirely.

https://www.project-syndicate.org/commentary/prizes--not-pat...

Re:Open-weight AI is having its Kubernetes moment. Let's not... by Geezus_42 on Saturday July 25, 2026 @05:04PM (#49051554)
Salk didn't need that temporary monopoly to invent the polio vaccine, which has gone on to be one of the biggest success stories of vaccines and modern medicine general.
Re:Open-weight AI is having its Kubernetes moment. Let's not... by ncallaway on Saturday July 25, 2026 @06:10PM (#49052158)
Okay? Does that disagree with anything I wrote?

My point was to whether it was artificial not whether it was bad.

We can have artificial interventions in markets, and that can be a net benefit and a good thing.

I’m not sure why everyone is responding as if “artificial” and “bad” are the same thing

Re:Open-weight AI is having its Kubernetes moment. Let's not... by wredcoll on Saturday July 25, 2026 @06:42PM (#49052484)
What percentage of research is performed outside of the companies? (by college/government)